Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Acular approved in U.S. for postoperative ocular inflammation

Jan. 7, 1997

Ciprofloxacin ophthalmic solution effective in treating bacterial corneal ulcers

Jan. 3, 1997

Pilocarpine TDS shows antiglaucoma activity in patients

Jan. 2, 1997

Further approval for breakthrough glaucoma medication

Dec. 30, 1996

FDA ophthalmic devices committee meetings scheduled for January

Dec. 24, 1996

NIH offers anticataract invention for licensing

Dec. 20, 1996

DuPont Merck reports ester prodrugs for glaucoma

Dec. 19, 1996

VISX supplemental PMA slated for review

Dec. 12, 1996

InSite Vision completes preliminary clinical trial of ophthalmic drug candidate

Dec. 9, 1996

Neuregulin polypeptides described for treating retinal disorders

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.